Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole

Gastrointestinal Endoscopy

Volumn 51, Issue 6, 2000, Pages 659-663

  Schulz, Heinrich ^a,b   Miehlke, Stephan ^a,b   Antos, David ^a,b   Schentke, Klaus Ulrich ^a,b   Vieth, Michael ^a,b   Stolte, Manfred ^a,b   Bayerdoörffer, Ekkehard ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARGON LASER; ARTICLE; BARRETT ESOPHAGUS; DRUG EFFICACY; DRUG MEGADOSE; ENDOSCOPIC SURGERY; ESOPHAGUS STRICTURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0034123371     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2000.105774     Document Type: Article

References (38)

1. Spechler S, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
2. Falk GW, Richter JE. Reflux disease and Barrett's esophagus. Endoscopy 1996;28:13-21.
3. Phillips RW, Wong RKH. Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol Clin North Am 1991;20:791-816.
4. Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997;92:27-31.
5. Lieberman DA, Oehlke M, Helfand M, the GORGE Consortium. Risk factors for Barrett's esophagus in a community-based practice. Am J Gastroenterol 1997;92:1293-7.
6. Fahmy N, King JF. Barrett's esophagus: an acquired condition with genetic predisposition. Am J Gastroenterol 1993;88:1262-5.
7. Eng C, Spechler SJ, Ruben R, Li FP. Familial Barrett's esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 1993;2:397-9.
8. Romero Y, Cameron AJ, Locke GR, Schaid DJ, Slezak JM, Branch CD, Melton LJ. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal carcinoma. Gastroenterology 1997;113:1449-56.
9. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
10. Hameeteman W, Tytgat GNJ, Houthoff HJ, Van Den Theel JG. Barrett's oesophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
11. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
12. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adencarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
13. Menke-Pluymers MBE, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenoacarcinoma in columnar-lined (Barrett) esophagus: the Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:155-8.
14. Clark GWB, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Barrett's metaplasia the source of adenocarcinoma of the gastric cardia. Arch Surg 1994;129:609-14.
15. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997;114:824-9.
16. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology [letter]? Lancet 1997;350:933.
17. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
18. Menke-Pluymers MBE, Schoute NW, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's esophagus. Gut 1992;33:1454-8.
19. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
20. Deviere J, Buset M, Dumonceau JM, Rickaert F, Cremer M. Regression of Barrett's epithelium with omeprazole. N Engl J Med 1989;320:1497-8.
21. Gore S, Healey CJ, Sutton R, Eyre-Brook IA, Gear MWL, Shepherd NA. The regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
22. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
23. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996;110:614-21.
24. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, 'carditis', and Barrett's esophagus and sequelae of therapy. Am J Surg Pathol 1996;20(Suppl):S31-50.
25. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992;69:8-16.
26. Falk GW, Richter JE. Reflux disease and Barrett's esophagus. Endoscopy 1998;30:61-72.
27. Bradham CP, Jones RL, Biddlestone LR, Hardwick RH, Sheperd NH, Barr H. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997;41:281-4.
28. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C. Photodynamic ablation of high-grade dysplasia and early gastric cancer in Barrett's esophagus by means of 5-aminole-vulinic acid. Gastroenterology 1998;114;448-55.
29. Van Laethem JL, Cremer M, Peny MO, Delhaye M, Devière J. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998;43:747-51.
30. Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy 1997;29:751-3.
31. Byrne JP, Armstrong GR, Attwood SEA. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998;93:1810-5.
32. Mork H, Barth T, Kreipe HH, Kraus M, Al-Zaie O, Jakob F, Scheurlen M. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopicargonplasma coagulation: a prospective study. Scand J Gastroenterol 1998;33:1130-4.
33. Porthun M, Brand B, Thonke F, Bohnacher S, Seitz U, Binmoeller KF, et al. Endoscopic therapy of Barrett's esophagus using argon plasma coagulation (APC) [abstract]. Gastroenterology 1998;114:A260.
34. Grade AJ, Shah IA, Medlin SM, Ramirez FC. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus [abstract]. Gastrointest Endosc 1998;47:AB30.
35. Ouatu-Lascar R, Fitzgerald RC, Omary MB, Triadafilopoulos G. Normalization of intraesophageal pH enhances differentiation and decreases proliferation in Barrett's esophagus [abstract]. Gastroenterology 1998;144:A660.
36. Fass R, Yalam JM, Camargo L, Johnson C, Garewal HS, Sampliner RE. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Dig Dis Sci 1997;9:1853-8.
37. Van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
38. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective long-term endoscopic and histological follow-up of short-segment Barrett's esophagus: comparison with traditional long-segment Barrett's esophagus. Am J Gastroenterol 1997;92:407-13.